Close

Royal Cargo passes GDP re-certification audit for pharma logistics

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

How Language Barriers Impact Non-Native English Speakers in Healthcare

Language barriers create significant challenges for non-native English speakers...

FDA Approval of AMVUTTRA for ATTR Amyloidosis

Alnylam Pharmaceuticals, Inc., a global leader in RNAi therapeutics,...

Rina-S Shows Promise in Advanced Ovarian Cancer

Genmab has reported encouraging findings from the Phase 2...

Pharma Support Powers Sofinnova Biotech Acceleration Fund

Sofinnova Partners Closes €165M Biotech Acceleration Fund with Strong...

Royal Cargo has announced that its Pharma/Clinical Trial Logistics and Premium Courier Service unit passed the Good Distribution Practices (GDP) re-certification audit.

Pharma Logistics is a business unit of this Philippines-based company that provides Logistics Management Solutions for Pharmaceutical and biotechnological industries.

The representations of international certification body TUV Rheinland Philippines reviewed documents and records and inspected the warehouse.

Post the inspection, the auditors noted positive observations and opportunities for improvements, and therefore recommended Pharma Logistics for re-certification.

Pharma Logistics was commended for its commitment to continually improve the system for GDP and for consistently maintaining the Good Warehousing and Distribution Practices inside the facility.

Royal Cargo Pharma Logistics is the first Good Distribution Practices (GDP) certified Logistics Service Provider in the Philippines. The unit is headed by Allan Soriano, Vice President for Pharma Logistics.

Good Distribution Practices (GDP) Certification for Pharmaceuticals demonstrates dedication to good distributive practices and quality in every aspect of service.

Latest stories

Related stories

How Language Barriers Impact Non-Native English Speakers in Healthcare

Language barriers create significant challenges for non-native English speakers...

FDA Approval of AMVUTTRA for ATTR Amyloidosis

Alnylam Pharmaceuticals, Inc., a global leader in RNAi therapeutics,...

Rina-S Shows Promise in Advanced Ovarian Cancer

Genmab has reported encouraging findings from the Phase 2...

Pharma Support Powers Sofinnova Biotech Acceleration Fund

Sofinnova Partners Closes €165M Biotech Acceleration Fund with Strong...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back